{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:11:41Z","timestamp":1789582301144,"version":"build-2803163510"},"reference-count":40,"publisher":"Baishideng Publishing Group Inc.","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2009]]},"DOI":"10.3748\/wjg.15.853","type":"journal-article","created":{"date-parts":[[2009,2,22]],"date-time":"2009-02-22T03:33:42Z","timestamp":1235273622000},"page":"853","source":"Crossref","is-referenced-by-count":67,"title":["Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach"],"prefix":"10.3748","volume":"15","author":[{"given":"Katsunori","family":"Iijima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pentti","family":"Sipponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tooru","family":"Shimosegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"IARC monographs on the evaluation of carcinogenic risks to humans. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori Lyon: International Agency for Research on Cancer; 1994;218-220."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Valle J, Kekki M, Sipponen P, Ihamaki T, Siurala M. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 1996;31:546-550.","DOI":"10.3109\/00365529609009126"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Maaroos HI, Vorobjova T, Sipponen P, Tammur R, Uibo R, Wadstrom T, Keevallik R, Villako K. An 18-year follow-up study of chronic gastritis and Helicobacter pylori association of CagA positivity with development of atrophy and activity of gastritis. Scand J Gastroenterol 1999;34:864-869.","DOI":"10.1080\/003655299750025318"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985;35:173-177.","DOI":"10.1002\/ijc.2910350206"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789.","DOI":"10.1056\/NEJMoa001999"},{"key":"ref6","unstructured":"Correa P, Haenszel W, Cuello C, Zavala D, Fontham E, Zarama G, Tannenbaum S, Collazos T, Ruiz B. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res 1990;50:4737-4740."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Filipe MI, Munoz N, Matko I, Kato I, Pompe-Kirn V, Jutersek A, Teuchmann S, Benz M, Prijon T. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994;57:324-329.","DOI":"10.1002\/ijc.2910570306"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, Yoshikawa A, Yanaoka K, Arii K, Tamai H. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109:138-143.","DOI":"10.1002\/ijc.11680"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187-194.","DOI":"10.1001\/jama.291.2.187"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Sipponen P, Seppala K, Aarynen M, Helske T, Kettunen P. Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis. Gut 1989;30:922-929.","DOI":"10.1136\/gut.30.7.922"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Sipponen P, Graham DY. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol 2007;42:2-10.","DOI":"10.1080\/00365520600863720"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Ito M, Haruma K, Kamada T, Mihara M, Kim S, Kitadai Y, Sumii M, Tanaka S, Yoshihara M, Chayama K. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther 2002;16:1449-1456.","DOI":"10.1046\/j.1365-2036.2002.01311.x"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Malfertheiner P, Sipponen P, Naumann M, Moayyedi P, Megraud F, Xiao SD, Sugano K, Nyren O. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol 2005;100:2100-2115.","DOI":"10.1111\/j.1572-0241.2005.41688.x"},{"key":"ref14","unstructured":"Borody TJ, Andrews P, Jankiewicz E, Ferch N, Carroll M. Apparent reversal of early gastric mucosal atrophy after triple therapy for Helicobacter pylori. Am J Gastroenterol 1993;88:1266-1268."},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-781.","DOI":"10.1136\/gut.2006.101634"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Karnes WE Jr, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SW, Walsh JH. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101:167-174.","DOI":"10.1016\/0016-5085(91)90474-Y"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Varis K, Kekki M, Harkonen M, Sipponen P, Samloff IM. Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer. Scand J Gastroenterol Suppl 1991;186:117-123.","DOI":"10.3109\/00365529109103998"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Knight T, Wyatt J, Wilson A, Greaves S, Newell D, Hengels K, Corlett M, Webb P, Forman D, Elder J. Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups. Br J Cancer 1996;73:819-824.","DOI":"10.1038\/bjc.1996.144"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Broutet N, Plebani M, Sakarovitch C, Sipponen P, Megraud F. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer 2003;88:1239-1247.","DOI":"10.1038\/sj.bjc.6600877"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Aromaa A, Kosunen TU, Knekt P, Maatela J, Teppo L, Heinonen OP, Harkonen M, Hakama MK. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol 1996;144:142-149.","DOI":"10.1093\/oxfordjournals.aje.a008901"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Borch K, Axelsson CK, Halgreen H, Damkjaer Nielsen MD, Ledin T, Szesci PB. The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroenterol 1989;24:870-876.","DOI":"10.3109\/00365528909089228"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 2003;98:735-739.","DOI":"10.1111\/j.1572-0241.2003.07410.x"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999;44:693-697.","DOI":"10.1136\/gut.44.5.693"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Kiyohira K, Yoshihara M, Ito M, Haruma K, Tanaka S, Chayama K. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels. J Gastroenterol 2003;38:332-338.","DOI":"10.1007\/s005350300060"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Shiotani A, Iishi H, Uedo N, Kumamoto M, Nakae Y, Ishiguro S, Tatsuta M, Graham DY. Histologic and serum risk markers for noncardia early gastric cancer. Int J Cancer 2005;115:463-469.","DOI":"10.1002\/ijc.20852"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Urita Y, Hike K, Torii N, Kikuchi Y, Kanda E, Sasajima M, Miki K. Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis. Dig Dis Sci 2004;49:795-801.","DOI":"10.1023\/B:DDAS.0000030091.92379.91"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, Doi H, Yoshida H, Kawabe T, Omata M. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005;54:764-768.","DOI":"10.1136\/gut.2004.055400"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Sipponen P, Ranta P, Helske T, Kaariainen I, Maki T, Linnala A, Suovaniemi O, Alanko A, Harkonen M. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol 2002;37:785-791.","DOI":"10.1080\/gas.37.7.785.791"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Vaananen H, Vauhkonen M, Helske T, Kaariainen I, Rasmussen M, Tunturi-Hihnala H, Koskenpato J, Sotka M, Turunen M, Sandstrom R. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003;15:885-891.","DOI":"10.1097\/00042737-200308000-00009"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Mernova VP, Polyakova MB. Possibility of non-invasive diagnosis of gastric mucosal precancerous changes. World J Gastroenterol 2004;10:3146-3150.","DOI":"10.3748\/wjg.v10.i21.3146"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Sipponen P, Valle J, Varis K, Kekki M, Ihamaki T, Siurala M. Fasting levels of serum gastrin in different functional and morphologic states of the antrofundal mucosa. An analysis of 860 subjects. Scand J Gastroenterol 1990;25:513-519.","DOI":"10.3109\/00365529009095523"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Kuipers EJ, Pals G, Pena AS, van Uffelen CW, Kok A, Westerveld BD, Meuwissen SG. Helicobacter pylori, pepsinogens and gastrin: relationship with age and development of atrophic gastritis. Eur J Gastroenterol Hepatol 1996;8:153-156.","DOI":"10.1097\/00042737-199602000-00012"},{"key":"ref33","unstructured":"Farinati F, Di Mario F, Plebani M, Cielo R, Fanton MC, Valiante F, Masiero M, De Boni M, Della Libera G, Burlina A. Pepsinogen A\/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer? Ital J Gastroenterol 1991;23:194-196."},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Sipponen P, Vauhkonen M, Helske T, Kaariainen I, Harkonen M. Low circulating levels of gastrin-17 in patients with Barrett's esophagus. World J Gastroenterol 2005;11:5988-5992.","DOI":"10.3748\/wjg.v11.i38.5988"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer 2006;9:245-253.","DOI":"10.1007\/s10120-006-0397-0"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Hattori Y, Tashiro H, Kawamoto T, Kodama Y. Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens. Jpn J Cancer Res 1995;86:1210-1215.","DOI":"10.1111\/j.1349-7006.1995.tb03317.x"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Oishi Y, Kiyohara Y, Kubo M, Tanaka K, Tanizaki Y, Ninomiya T, Doi Y, Shikata K, Yonemoto K, Shirota T. The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study. Am J Epidemiol 2006;163:629-637.","DOI":"10.1093\/aje\/kwj088"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Plummer M, Buiatti E, Lopez G, Peraza S, Vivas J, Oliver W, Munoz N. Histological diagnosis of precancerous lesions of the stomach: a reliability study. Int J Epidemiol 1997;26:716-720.","DOI":"10.1093\/ije\/26.4.716"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, Leandro G, Price AB, Sipponen P, Solcia E. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002;16:1249-1259.","DOI":"10.1046\/j.1365-2036.2002.01301.x"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"van Grieken NC, Weiss MM, Meijer GA, Bloemena E, Lindeman J, Offerhaus GJ, Meuwissen SG, Baak JP, Kuipers EJ. Rapid quantitative assessment of gastric corpus atrophy in tissue sections. J Clin Pathol 2001;54:63-69.","DOI":"10.1136\/jcp.54.1.63"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i7\/853.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T05:12:46Z","timestamp":1558156366000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i7\/853.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.15.853","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}